Review
Published on 28 Nov 2024
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1506767
Type at least 3 characters
555 articles
Articles
Original Research
Accepted on 25 Nov 2024
Pharmacogenetic and pharmacokinetic factors for dexmedetomidine-associated hemodynamic instability in pediatric patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1515523
Original Research
Published on 25 Nov 2024
Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500235
- 188 views
Brief Research Report
Accepted on 22 Nov 2024
Clinical implications of a gain of function genetic polymorphism in DPYD (rs4294451) in colorectal cancer patients treated with fluoropyrimidines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516375
- 128 views
Original Research
Published on 20 Nov 2024
Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490892
- 143 views
Review
Accepted on 19 Nov 2024
Pediatric Flecainide Pharmacogenomics: A Roadmap to Deliver Precision Based Care to Pediatrics Arrhythmias
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477485
Original Research
Published on 18 Nov 2024
Investigation on regulation of N-acetyltransferase 2 expression by nuclear receptors in human hepatocytes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488367
- 240 views
Original Research
Published on 15 Nov 2024
Population pharmacokinetic study of the effect of polymorphisms in the ABCB1 and CES1 genes on the pharmacokinetics of dabigatran
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454612
- 178 views
Original Research
Published on 14 Nov 2024
Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480657
- 194 views
Original Research
Accepted on 13 Nov 2024
Integration of pharmacogenetic data in Epic Genomic Module drives best practice alerts
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458095
- 152 views
Review
Published on 12 Nov 2024
Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1442888
- 462 views
Original Research
Accepted on 08 Nov 2024
Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490878
Original Research
Published on 01 Nov 2024
Multi-omics association study integrating GWAS and pQTL data revealed MIP-1α as a potential drug target for erectile dysfunction
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1495970
- 557 views
Original Research
Published on 01 Nov 2024
Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466394
- 420 views
Review
Accepted on 30 Oct 2024
Pharmacogenomics For Neurodegenerative Disorders -A Focused Review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478964
Original Research
Published on 30 Oct 2024
The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1483723
- 386 views